Alcoholic hepatitis
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Alcoholic hepatitis is caused be excessive consumption of alcohol. In US, 7.2% of adults suffer from alcohol use disorder. Symptoms of Alcoholic hepatitis may vary from mild to severe; therefore; any suspected patient should undergo liver function test and ultrasound to screen for Alcoholic hepatitis. Alcoholic hepatitis may progress to hepatic steatonecrosis,fibrosis, cirrhosis or hepatocellular carcinoma. Consequently, all patients must be advised for alcohol abstinence. Additionally, nutritional supplements including folic acid, thiamine, vitamin B6, vitamin A and zinc can be provided. If Alcoholic hepatitis progress to cirrhosis, liver transplant will be considered for treatment.
Historical Perspective
Alcoholic hepatitis was first recognized in 1961 after investigation of 7 cases with excessive alcohol intake . Before the recognition of Alcoholic hepatitis, it was believed that the symptoms are caused by malnutrition not due to toxic effects of alcohol. Charles S. Lieber developed modern research on alcohol-related liver disease.
Pathophysiology
The pathophysiology of Alcoholic hepatitis is caused by interplay between alcohol metabolism, inflammation and innate immunity. Alcohol metabolism leads to depletion of NAD and subsequent lipogenesis. Additionally, increased endotoxemia causes translocation of lipopolysaccharide from intestine to hepatocytes. In hepatocytes, lipopolysaccharide activates kupffer cells. Therefore, activated cells release inflammatory markers which lead to Alcoholic hepatitis.
Causes
Alcohol is a significant cause of Alcoholic hepatitis. Other factors that may associate with Alcoholic hepatitis are hepatitis C and malnutrition.
Differentiating Alcoholic Hepatitis from other Diseases
Alcoholic Hepatitis should be differentiated from viral hepatitis, autoimmune hepatitis, non-alcoholic fatty liver disease, drug-induced liver injury, Wilson disease, cholestatic causes of liver disease, and hepatocellular carcinoma.
Epidemiology and Demographics
In US, 7.2% of adults suffer from alcohol use disorder.The peak incidence of Alcoholic hepatitis is between 20-60 years of age.In 2007, Alcoholic hepatitis was accounted for 0.71% of all hospital admissions in US. Women are at greater risk of developing Alcoholic hepatitis after shorter duration and smaller amount of alcohol intake.
Risk Factors
The most commonrisk factors of developing Alcoholic hepatitis include heavy alcohol intake, High body mass index, Female gender , Malnutrition and hepatitis C.
Screening
Patients with excessive alcohol intake requires screening for alcohol use with AUDIT questionnaire. If the score is above 8, Alcohol use disorder is diagnosed and patient requires further evaluation by performing liver test and liver ultrasound.
Natural history, Complications and Prognosis
Alcoholic liver disease may progress to fatty liver, hepaticsteatosis, Alcoholic hepatitis or alcoholic steatonecrosis,fibrosis, cirrhosis and hepatocellular carcinoma. Complications of Alcoholic hepatitis include [[variceal hemorrhage,hepatic encephalopathy,ascites,coagulopathy, thrombocytopenia,spontaneous bacterial peritonitis, and iron overload. Different scoring systems were presented to predict the prognosis and mortality among patients with Alcoholic hepatitis. The most recent and accurate one is called Asymmetric dimethylarginine (ADMA) score.
Diagnosis
History and Symptoms
Alcoholic hepatitis is suspected to occur in patients with excessive drinking over the decades.Symptoms of Alcoholic hepatitis can vary from mild to severe.The symptoms include nausea,malaise, low-grade fever, abdominal Pain, yellow discoloration of skin increased abdominal girth due to ascites, gastrointestinal bleeding due to variceal hemorrhage, lack of appetite, confusion, and lethargy.
Physical Examination
Physical examination findings include fever, tachycardia, tachypnea,respiratory alkalosis,hepatomegaly,hepatic tenderness ,scleral icterus,splenomegaly, ascites,ssterixis, darkening of the urine, peripheral edema,gynecomastia,palmer erythema,Spider angiomas, altered hair distribution, Proximal muscle wasting.
Laboratory Findings
The most frequent laboratory findings of Alcoholic hepatitis include neutrophilic leukocytosis with bandemia,anemia ,AST/ALT ratio greater than 2, mild elevation of Alkaline Phosphatase, hypoalbuminemia, hyperbilirubinemia,prolonged prothrombin time, and elevated gamma-glutamyl transpeptidase level.
X-Ray
There are no x-ray findings associated with Alcoholic hepatitis.
CT
CT scan is usually performed among patients with Alcoholic hepatitis to exclude other abnormalities including neoplasm, biliary obstruction or infiltrative liver disease.CT scan can predict severity and outcome of Alcoholic hepatitis by presence of splenomegaly, ascites, varices, liver length to mid clavicular line, decreased liver attenuation, liver to spleen attenuation ratio and increased liver heterogenecity.
MRI
MRI findings of Alcoholic hepatitis are non-specific is usually done to exclude other etiologies and include hepatic steatosis, increase T2 signal around portal system, and Increased intensity in parenchymal signal.
Ultrasound
Ultrasound is the first choice of imaging test in Alcoholic hepatitis. The finding are hepatomegaly,irregular outline of liver surface and edge nodularity, diffuse hyper-echoic liver,Atrophy of right lobe. Additionally, splenomegaly, varices and [ascites]] are suggestive features of portal hypertension.
Other Diagnostic Studies
Liver biopsy is indicated in patients whose diagnosis is uncertain and in patients with severe Alcoholic hepatitis who are probable to undergo medical treatment. Liver biopsy in Alcoholic Hepatitis include Polymorphonuclear infiltration, hepatic necrosis, Mallory bodies in hepatocytes, perivenular and perisinusoidal fibrosis, ballooning hepatocytes, and steatosis.
Treatment
Medical Therapy
All patients with Alcoholic Hepatitis must be advised to stopped alcohol use. Additionally, nutritional supplements including folic acid, thiamine, vitamin B6, vitamin A and zinc can be provided. Glucocorticoids is the most common pharmacologic treatment in Alcoholic hepatitis .Pentoxifylline can be used in patient with contraindication to steroids.
Surgery
Liver transplant is considered in case of cirrhosis. Orthotopic liver transplant is the definitive surgical treatment for hepatic failure associated with Alcoholic Hepatitis. Prior to liver transplant, 6 months of abstinence is required.
Primary Prevention
The primary prevention of Alcoholic hepatitis is alcohol abstinence.Alcohol abstinence improves histological features of hepatic injury and reduces portal hypertension and the risk of cirrhosis. Risk of recidivism is 67% to 81% after alcohol abstinence; therefore, combination psychotherapy with cognitive behavioral therapy, peer driven support counseling, motivational enhancement therapy, and comprehensive medical care.
Secondary Prevention
Disulfiram, naltrexone, and acamprosate are used to to maintain alcohol abstinence.Additionally, baclofen and gamma hydroxyl butyrate are options to reduce recidivism in patients with advanced chronic liver disease.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Alcoholic hepatitis was first recognized in 1961 after investigation of 7 cases with excessive alcohol intake . Before the recognition of Alcoholic Hepatitis, it was believed that the symptoms are caused by malnutrition not due to toxic effects of alcohol. Charles S. Lieber developed modern research on alcohol-related liver disease.
Historical Perspective
- In 1950s, it was believed that alcohol-related liver damage is due to malnutrition rather than toxic effects of alcohol.[1]
- In 1961, Beckett and his colleagues used the term Alcoholic Hepatitis for the first time.[2]
- Beckett et al. investigated 7 cases of acute Alcoholic Hepatitis and their features at Royal Free Hospital in Great Britain during 1953-1961.[2]
- Charles S. Lieber was the first one who developed modern research on alcohol and alcohol-related liver damage.[1]
References
- ↑ 1.0 1.1 Neuman, M. G.; Cohen, L.; Zakhari, S.; Nanau, R. M.; Mueller, S.; Schneider, M.; Parry, C.; Isip, R.; Seitz, H. K. (2014). “Alcoholic Liver Disease: A Synopsis of the Charles Lieber’s Memorial Symposia 2009-2012”. Alcohol and Alcoholism. 49 (4): 373–380. doi:10.1093/alcalc/agu021. ISSN 0735-0414.
- ↑ 2.0 2.1 Beckett, A. G.; Livingstone, A. V.; Hill, K. R. (1961). “Acute Alcoholic Hepatitis”. BMJ. 2 (5260): 1113–1119. doi:10.1136/bmj.2.5260.1113. ISSN 0959-8138.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]Prashanth Saddala M.B.B.S
Overview
The pathophysiology of Alcoholic Hepatitis is caused by interplay between alcohol metabolism, inflammation and innate immunity. Alcohol metabolism leads to depletion of NAD and subsequent lipogenesis. Additionally, increased endotoxemia causes translocation of lipopolysaccharide from intestine to hepatocytes. In hepatocytes, lipopolysaccharide activates kupffer cells. Therefore, activated cells release inflammatory markers which lead to Alcoholic hepatitis.
Pathophysiology
Pathogenesis
- The pathogenesis of Alcoholic Hepatitis is multifactorial.
- Alcoholic Hepatitis is caused by interplay between alcohol metabolism, inflammation and innate immunity. [1]
- Ethanol metabolism in the liver is carried out mainly by two enzymes:[2]
- Both of these enzymes use NAD+ as a cofactor. Alcohol is converted to acetaldehyde and acetaldehyde is then further oxidized to acetate. Acetaldehyde is the toxic metabolite in this process.
- The Alcohol metabolism leads to a reduced ratio of the nicotinamide adenine dinucleotide (NAD) to NADH. The NAD depletion inhibit fatty acid oxidation and causes fat accumulation in hepatocytes associated with lipogenesis. [1]
- Due to increased intestinal permeability in patients with Alcoholic Hepatitis, high levels of Endotoxemia is recognized.[1]
- Endotoxin binds to lipopolysaccharide and translocate from intestine to hepatocytes.[3]
- In hepatocytes, lipopolysaccharide bindes to CD14 molecule and toll-like receptor 4 on surface of Kupffer cells.[4]
- These bindings activate Kupffer cells to release reactive oxygen species.[3]
- This activation release tumor necrosis factor-alpha (TNF alpha), interleukin-8, monocyte chemotactic protein 1 (MCP-1), andplatelet-derived growth factor (PDGF) which are responsible for characterized symptoms including malaise, fever, and peripheral neutrophil leukocytosis. [5] [6]
Genetics
- Genetic predisposition in alcoholism and developing alcohol -related liver injury:[7]
- There is a significant association between ADH2, ADH3, and ALDH2 alleles and the risk of alcoholism
- The ADH2 and ADH3 alleles are associated with alcoholism in East Asians population
- The ADH2 allele is associated with alcoholism in Caucasians
- The association between genetic predisposition and development of alcoholic liver injury is unknown
- There is a significant association between ADH2, ADH3, and ALDH2 alleles and the risk of alcoholism
Associated Conditions
Conditions associated with alcoholic liver disease include:[2][8]
- Obesity
- Chronic viral hepatitis
- Iron overload
- Cirrhosis
- Hepatocellular carcinoma
Microscopic Pathology
On microscopic histopathological analysis characteristic findings of Alcoholic Hepatitis include:
- Steatosis
- Macrovesicular steatosis – the cytoplasm of hepatocytes is occupied by large lipid droplets that end up displacing the nucleus and other organelles peripherally
- Mallory body
- A condition where pre-keratin filaments accumulate in hepatocytes. This sign is not limited to alcoholic liver disease.[9]
- Ballooning degeneration
- Hepatocytes in the setting of alcoholic change often swell up with excess fat, water and protein. Accompanied with ballooning, there is necrotic damage. The swelling blocks biliary ducts, leading to diffuse cholestasis.[9]
- Inflammation
- If chronic liver disease is also present:
References
- ↑ 1.0 1.1 1.2 Gao, Bin; Bataller, Ramon (2011). “Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets”. Gastroenterology. 141 (5): 1572–1585. doi:10.1053/j.gastro.2011.09.002. ISSN 0016-5085.
- ↑ 2.0 2.1 Ceni E, Mello T, Galli A (2014). “Pathogenesis of alcoholic liver disease: role of oxidative metabolism”. World J. Gastroenterol. 20 (47): 17756–72. doi:10.3748/wjg.v20.i47.17756. PMC 4273126. PMID 25548474.
- ↑ 3.0 3.1 Bautista, Abraham P (2001). “Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease“. Journal of Gastroenterology and Hepatology. 15 (4): 349–356. doi:10.1046/j.1440-1746.2000.02174.x. ISSN 0815-9319.
- ↑ Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R (2015). “Alcoholic hepatitis: The pivotal role of Kupffer cells”. World J Gastrointest Pathophysiol. 6 (4): 90–8. doi:10.4291/wjgp.v6.i4.90. PMC 4644891. PMID 26600966.
- ↑ Bird G (1994). “Interleukin-8 in alcoholic liver disease”. Acta Gastroenterol Belg. 57 (3–4): 255–9. PMID 7810274.
- ↑ Laso FJ, Lapeña P, Madruga JI, San Miguel JF, Orfao A, Iglesias MC; et al. (1997). “Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake”. Alcohol Clin Exp Res. 21 (7): 1226–31. PMID 9347083.
- ↑ Zintzaras E, Stefanidis I, Santos M, Vidal F (2006). “Do alcohol-metabolizing enzyme gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?”. Hepatology. 43 (2): 352–61. doi:10.1002/hep.21023. PMID 16440362.
- ↑ Lucey, Michael R.; Mathurin, Philippe; Morgan, Timothy R. (2009). “Alcoholic Hepatitis”. New England Journal of Medicine. 360 (26): 2758–2769. doi:10.1056/NEJMra0805786. ISSN 0028-4793.
- ↑ 9.0 9.1 9.2 Cotran. Robbins Pathologic Basis of Disease. Philadelphia: W.B Saunders Company. 0-7216-7335-X. Unknown parameter
|coauthors=ignored (help)
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Alcohol is a significant cause of Alcoholic hepatitis. Other factors that may associate with Alcoholic Hepatitis are hepatitis C and malnutrition.
Causes
- Alcohol is a significant cause of Alcoholic hepatitis [1]
- Alcoholic Hepatitis is identified by chronic, heavy alcohol consumption 3- 4 weeks before presenting one of the following signs or symptoms :
- Jaundice
- Fever
- Tachycardia
- Tachypnea
- Hepatomegaly
- Leukocytosis with neutrophilia
- AST:ALT> 1.5:1
- A typical patient is someone who aged 40-60 with history of more than 100 g/day alcohol intake for more than a decade. [2]
- The progression of Alcoholic Hepatitis is not depended on either amount or the duration of alcohol consumption.
- Other factors that may associate with Alcoholic Hepatitis:[2]
References
- ↑ “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
- ↑ 2.0 2.1 Milosevic I, Vujovic A, Barac A, Djelic M, Korac M, Radovanovic Spurnic A; et al. (2019). “Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature”. Int J Mol Sci. 20 (2). doi:10.3390/ijms20020395. PMC 6358912. PMID 30658519.
Differentiating Alcoholic hepatitis from other Diseases
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Alcoholic Hepatitis should be differentiated from viral hepatitis, autoimmune hepatitis, non-alcoholic fatty liver disease, drug-induced liver injury, Wilson disease, cholestatic causes of liver disease, and cirrhosis.
Differentiating Alcoholic hepatitis from other Diseases
Alcoholic hepatitis can be differentiated from other liver diseases based on the presence of jaundice and other symptoms including fever and abdominal pain.[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16]
Abbreviations:
RUQ= Right upper quadrant of the abdomen, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CT= Computed tomography
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Stickel F, Seitz HK (2013). “Update on the management of alcoholic steatohepatitis”. J Gastrointestin Liver Dis. 22 (2): 189–97. PMID 23799218.
- ↑ Mathurin P, Lucey MR (2012). “Management of alcoholic hepatitis”. J. Hepatol. 56 Suppl 1: S39–45. doi:10.1016/S0168-8278(12)60005-1. PMID 22300464.
- ↑ Hamberg KJ, Carstensen B, Sørensen TI, Eghøje K (1996). “Accuracy of clinical diagnosis of cirrhosis among alcohol-abusing men”. J Clin Epidemiol. 49 (11): 1295–301. PMID 8892498.
- ↑ Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A (1996). “Cirrhosis and muscle cramps: evidence of a causal relationship”. Hepatology. 23 (2): 264–73. doi:10.1002/hep.510230211. PMID 8591851.
- ↑ Burra P, Germani G, Masier A, De Martin E, Gambato M, Salonia A, Bo P, Vitale A, Cillo U, Russo FP, Senzolo M (2010). “Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?”. Transplantation. 89 (12): 1425–9. doi:10.1097/TP.0b013e3181e1f1f6. PMID 20463637.
- ↑ Torruellas C, French SW, Medici V (2014). “Diagnosis of alcoholic liver disease”. World J. Gastroenterol. 20 (33): 11684–99. doi:10.3748/wjg.v20.i33.11684. PMC 4155359. PMID 25206273.
- ↑ Baraona E, Leo MA, Borowsky SA, Lieber CS (1975). “Alcoholic hepatomegaly: accumulation of protein in the liver”. Science. 190 (4216): 794–5. PMID 1198096.
- ↑ Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). “Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial”. Gastroenterology. 119 (6): 1637–48. PMID 11113085.
- ↑ Mendenhall CL, Anderson S, Weesner RE, Goldberg SJ, Crolic KA (1984). “Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis”. Am. J. Med. 76 (2): 211–22. PMID 6421159.
- ↑ Pirovino M, Linder R, Boss C, Köchli HP, Mahler F (1988). “Cutaneous spider nevi in liver cirrhosis: capillary microscopical and hormonal investigations”. Klin. Wochenschr. 66 (7): 298–302. PMID 3131572.
- ↑ Dutta SK, Dukehart M, Narang A, Latham PS (1989). “Functional and structural changes in parotid glands of alcoholic cirrhotic patients”. Gastroenterology. 96 (2 Pt 1): 510–8. PMID 2910764.
- ↑ Van Thiel DH, Gavaler JS, Schade RR (1985). “Liver disease and the hypothalamic pituitary gonadal axis”. Semin. Liver Dis. 5 (1): 35–45. doi:10.1055/s-2008-1041756. PMID 3983651.
- ↑ Epstein O, Dick R, Sherlock S (1981). “Prospective study of periostitis and finger clubbing in primary biliary cirrhosis and other forms of chronic liver disease”. Gut. 22 (3): 203–6. PMC 1419499. PMID 7227854.
- ↑ Attali P, Ink O, Pelletier G, Vernier C, Jean F, Moulton L, Etienne JP (1987). “Dupuytren’s contracture, alcohol consumption, and chronic liver disease”. Arch. Intern. Med. 147 (6): 1065–7. PMID 3592873.
- ↑ Erlinger S, Benhamou J. Cirrhosis: clinical aspects. In: Mcintyre N, Benhamou J, Rizzetto M, editors. Oxford textbook of clinical hepatology. Oxford: University Press; 1991. p. 380.
- ↑ Groszman R, Franchis R. Portal hypertension. In: Schiff E, Sorrell M, Maddrey W, editors. Diseases of the liver. Philadelphia: Lippincot Williams & Wilkens; 1999. p. 415.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
In US, 7.2% of adults suffer from alcohol use disorder.The peak incidence of Alcoholic Hepatitis is between 20-60 years of age.In 2007, Alcoholic Hepatitis was accounted for 0.71% of all hospital admissions in US. Women are at greater risk of developing Alcoholic Hepatitis after shorter duration and smaller amount of alcohol intake.
Epidemiology and Demographics
Prevalence
- In US, 7.2% of adults suffer from alcohol use disorder.[1]
- In Western countries, alcoholis the cause of 80% of hepatotoxic deaths and 50% of liver cirrhosis.[3]
- According to a survey between 2001-2011 from 211 hospitals, Alcoholic Hepatitis was accounted for 0.08% to 0.09% of hospital admissions.
- Regarding to another study in 2007, Alcoholic Hepatitis was accounted for 0.71% of all hospital admissions in US.[4]
- The peak incidence of Alcoholic Hepatitis is between 20-60 years of age.
Gender
- Women are at greater risk of developing Alcoholic Hepatitis after shorter duration and smaller amount of alcohol intake .
References
- ↑ “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
- ↑ Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH (2018). “ACG Clinical Guideline: Alcoholic Liver Disease”. Am J Gastroenterol. 113 (2): 175–194. doi:10.1038/ajg.2017.469. PMC 6524956 Check
|pmc=value (help). PMID 29336434. - ↑ Testino G, Leone S, Fagoonee S, Pellicano R (2018). “Alcoholic liver fibrosis: detection and treatment”. Minerva Med. 109 (6): 457–471. doi:10.23736/S0026-4806.18.05844-5. PMID 30221911.
- ↑ Liangpunsakul S (2011). “Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States”. J Clin Gastroenterol. 45 (8): 714–9. doi:10.1097/MCG.0b013e3181fdef1d. PMC 3135756. PMID 21085006.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
The most commonrisk factors of developing Alcoholic Hepatitis include heavy alcohol intake, High body mass index, Female gender , Malnutrition and hepatitis C.
Risk Factors
- Risk factors related to Alcoholic Hepatitis include:[1][2][3][4]
- Alcohol ingestion> 10-20 g/day in women and > 20-40 g/day in men
- High body mass index (BMI)define as BMI > 27 kg/m2 in men and BMI > 25 kg/m2 in women
- Female gender
- Genetic variant of patatin-like phospholipase domain-containing protein 3 (PNPLA3)
- hepatitis C[5]
- Malnutrition
References
- ↑ Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF; et al. (1996). “Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study”. Hepatology. 23 (5): 1025–9. doi:10.1002/hep.510230513. PMID 8621128.
- ↑ Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M; et al. (1997). “Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group”. Gut. 41 (6): 845–50. doi:10.1136/gut.41.6.845. PMC 1891602. PMID 9462221.
- ↑ Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC; et al. (2002). “Risk factors of fibrosis in alcohol-induced liver disease”. Hepatology. 35 (3): 635–8. doi:10.1053/jhep.2002.31782. PMID 11870378.
- ↑ Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC (1997). “Excess weight risk factor for alcoholic liver disease”. Hepatology. 25 (1): 108–11. doi:10.1002/hep.510250120. PMID 8985274.
- ↑ Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O’Brien CP; et al. (2003). “Alcohol potentiates hepatitis C virus replicon expression”. Hepatology. 38 (1): 57–65. doi:10.1053/jhep.2003.50295. PMID 12829987.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Patients with excessive alcohol intake requires screening for alcohol use with AUDIT questionnaire. If the score is above 8, Alcohol use disorder is diagnosed and patient requires further evaluation by performing liver test and liver ultrasound.
Screening
- Patients with excessive alcohol intake requires screening for alcohol use with AUDIT questionnaire:[1]
- If AUDIT score ≤ 8:
- Patient doesn’t have alcohol use disorder
- If AUDIT> 8:
- Alcohol use disorder is diagnosed
- Check liver test; if abnormal:
- Refer to alcohol addiction specialist
- Refer to GI specialist/ hepatologist
- Non-invasive diagnostic tests are recommended such as Liver Ultrasound:
- Check liver test; if abnormal:
- Alcohol use disorder is diagnosed
- If AUDIT score ≤ 8:
References
- ↑ Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH (2018). “ACG Clinical Guideline: Alcoholic Liver Disease”. Am J Gastroenterol. 113 (2): 175–194. doi:10.1038/ajg.2017.469. PMC 6524956 Check
|pmc=value (help). PMID 29336434.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Alcoholic liver disease may progress to fatty liver, hepaticsteatosis, Alcoholic hepatitis, alcoholic steatonecrosis,fibrosis, cirrhosis and hepatocellular carcinoma. Complications of Alcoholic hepatitis include [[variceal hemorrhage,hepatic encephalopathy,ascites,Coagulopathy, thrombocytopenia,spontaneous bacterial peritonitis, and iron overload. Different scoring systems were presented to predict the prognosis and mortality among patients with Alcoholic hepatitis. The most recent and accurate one is called Asymmetric dimethylarginine (ADMA) score.
Natural history, complication, and prognosis
Natural history
- Alcoholic liver disease may progress to one of the following stages:[1] [2]
- Fatty liver or hepaticsteatosis
- Steatohepatitis defined as Alcoholic Hepatitis or alcoholic steatonecrosis
- Fibrosis
- Cirrhosis and hepatocellular carcinoma (HCC)
- The liver biopsy of around 20-40% of the individuals with steatosis is suggestive of steatohepatitis
- After development of steatohepatitis, the hepatic change is irreversible, even after the abstinence
Complication
- Complications of Alcoholic Hepatitis include: [3]
Prognosis
- Compared to steatosis, development of Alcoholic Hepatitis is associated with nine -times higher risk of developing cirrhosis as well as 40 % chance of 180- days mortality.[4]
- Continuing alcohol consumption can lead to development of cirrhosis in 70 % subjects with Alcoholic Hepatitis[5]
- Alcoholic Hepatitis is considered to be fatal as 1-year mortality rate among subjects is 25%. [6]
- The progression of precirrhotic disease to cirrhosis are reported as the following rates:[7]
- 1% (0-8%) for patients with normal histology
- 3% (2-4%) for hepatic steatosis
- 10% (6-17%) for steatohepatitis
- 8% (3-19%) for fibrosis
- Maddrey et al. described Discriminant Function (DF), is a predictor of severity of Alcoholic Hepatitis:[8]
- Model for End-Stage Liver Disease (MELD) predicts mortality risk in patients with end-stage liver disease[9]
- Glasgow Alcoholic Hepatitis Score (GAHS) is another scoring system which calculated the risk based on age, serum bilirubin, blood urea nitrogen, PT, and peripheral WBCcount [10]
- Asymmetric dimethylarginine (ADMA) score is the most recent predictor of severe Alcoholic Hepatitis [11]
- ADMA score is a better predictor of outcomes of Alcoholic Hepatitis than other scoring systems
References
- ↑ Testino G (2008). “Alcoholic diseases in hepato-gastroenterology: a point of view”. Hepatogastroenterology. 55 (82–83): 371–7. PMID 18613369.
- ↑ Testino G (2013). “Alcoholic hepatitis”. J Med Life. 6 (2): 161–7. PMC 3725441. PMID 23904876.
- ↑ “Alcoholic Hepatitis – StatPearls – NCBI Bookshelf”.
- ↑ Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ (2011). “Treatment of alcoholic liver disease”. Therap Adv Gastroenterol. 4 (1): 63–81. doi:10.1177/1756283X10378925. PMC 3036962. PMID 21317995.
- ↑ Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C; et al. (2018). “Alcoholic liver disease”. Nat Rev Dis Primers. 4 (1): 16. doi:10.1038/s41572-018-0014-7. PMID 30115921.
- ↑ Lourens S, Sunjaya DB, Singal A, Liangpunsakul S, Puri P, Sanyal A; et al. (2017). “Acute Alcoholic Hepatitis: Natural History and Predictors of Mortality Using a Multicenter Prospective Study”. Mayo Clin Proc Innov Qual Outcomes. 1 (1): 37–48. doi:10.1016/j.mayocpiqo.2017.04.004. PMC 6134907. PMID 30225400.
- ↑ Parker R, Aithal GP, Becker U, Gleeson D, Masson S, Wyatt JI; et al. (2019). “Natural history of histologically proven alcohol-related liver disease: A systematic review”. J Hepatol. 71 (3): 586–593. doi:10.1016/j.jhep.2019.05.020. PMID 31173814.
- ↑ O’Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases. Practice Parameters Committee of the American College of Gastroenterology (2010). “Alcoholic liver disease”. Hepatology. 51 (1): 307–28. doi:10.1002/hep.23258. PMID 20034030.
- ↑ Al Sibae MR, Cappell MS (2011). “Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS”. Dig Dis Sci. 56 (4): 977–87. doi:10.1007/s10620-010-1390-3. PMID 20844956.
- ↑ Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC; et al. (2005). “Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score”. Gut. 54 (8): 1174–9. doi:10.1136/gut.2004.050781. PMC 1774903. PMID 16009691.
- ↑ Mookerjee RP, Malaki M, Davies NA, Hodges SJ, Dalton RN, Turner C; et al. (2007). “Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis”. Hepatology. 45 (1): 62–71. doi:10.1002/hep.21491. PMID 17187433.
Diagnosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
